UCB (EBR:UCB) UCB Media Room: Share Repurchase Program 2022
Directive transparence : information réglementée Communiqué sur comptes, résultats, chiffres d’affaires
24/06/2022 20:05
https://mb.cision.com/Public/18595/3591268/a63dfcb3bb9bc1f5_800x800ar.png
** Share Repurchase Program 2022 to cover UCB's Long Term Incentive Plans f=
or employees
------------------------------------------------------------
Brussels (Belgium), 24 June 2022 =E2=80=93 20:05 (CEST) =E2=80=93 Regulated=
information=C2=A0
In application of article 7:215 of the Belgian Code of Companies and Associ=
ations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =E2=80=9CCompany) (Euronext=
Brussels: UCB) announces the launch of a share buy-back program (the =E2=
=80=9CShare Repurchase Program 2022=E2=80=9D), effective as of 28 June 2022=
.=C2=A0
The repurchase of UCB shares under this program intends to cover current an=
d future obligations under UCB's Long Term Incentive Plans for its employee=
s. UCB will continuously monitor both its current and future obligations un=
der such plans in view of keeping an adequate level of treasury shares.
Under this program, UCB may acquire from time to time its common stock, for=
a maximum of 500 000 UCB shares. The share repurchases until 30 June 2022 =
will be conducted under the terms and conditions approved by the extraordin=
ary general shareholders=E2=80=99 meeting of the Company held on 30 April 2=
020, and under the terms and conditions approved by the extraordinary gener=
al shareholders=E2=80=99 meeting of the Company held on 28 April 2022 for a=
ll share repurchases as from 1 July 2022. The timing of the repurchase of s=
hares pursuant to the program will depend on a variety of factors, includin=
g market conditions. The program may be suspended or discontinued at any ti=
me.
UCB has requested a financial intermediary to repurchase UCB shares on its =
behalf under the terms of a discretionary mandate agreement with initial va=
lidity until 31 August 2022.=C2=A0
During the Share Repurchase Program 2022, regular updates will be published=
in accordance with applicable legislation.
In the framework of UCB=E2=80=99s ongoing cash and treasury shares manageme=
nt, UCB may decide to enter into equity swap transactions, including during=
the term of this Share Repurchase Program 2022. Any such transaction will =
be reported in accordance with applicable legislation.
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://www.ucb.com/stories-media/Press-Releases) .
For further information, contact UCB:=C2=A0
Investor Relations
Antje Witte=C2=A0
T +32 2 559 94 14
antje.witte@ucb.com
Corporate Communications
Laurent Schots=C2=A0
T+32 2 559 92 64
laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With approximately 8 600 peopl=
e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi=
llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us =
on Twitter: @UCB_news
=C2=A0
GenericFile
220624 - PR UCB Aandelen Inkoop Programma 2022 NL final (https://mb.cision.=
com/Public/18595/3591268/a0f65bc615199129.pdf) GenericFile
220624 - PR Share Repurchase Program 2022 ENG final (https://mb.cision.com/=
Public/18595/3591268/81b1c5959ff69722.pdf) GenericFile
220624 - PR UCB Programme de rachat d actions propres 2022 FR final (https:=
//mb.cision.com/Public/18595/3591268/807f015a913e94a5.pdf)
______________________
If you would rather not receive future communications from UCB SA, please g=
o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x109264x1x6868579x2400=
0x6&Email=3Dregnews%40symexglobal.com.
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium
26/04/2024 20:00
25/04/2024 18:00
25/04/2024 07:01
23/04/2024 20:00
22/04/2024 07:01
19/04/2024 20:00
17/04/2024 07:01
12/04/2024 20:00
12/04/2024 18:01
12/04/2024 07:01